This topic contains a solution. Click here to go to the answer

Author Question: One advantage to the use of cyclosporine for the prevention of allograft rejection is that it does ... (Read 36 times)

melina_rosy

  • Hero Member
  • *****
  • Posts: 531
One advantage to the use of cyclosporine for the prevention of allograft rejection is that it does not:
 
  1. cause renal damage.
  2. weaken bones.
  3. suppress the bone marrow.
  4. increase the risk of infection.

Question 2

A nurse manages care for a patient who has been on cyclosporine for 9 months for the prevention of renal allograft rejection.
 
  The nurse reviews laboratory data and notes that the patient's blood urea nitrogen and serum creatinine have risen sharply in the last 2 weeks. In addition to nephrotoxicity, the nurse needs to assess the patient for:
  1. leukocytosis.
  2. an anaphylactic reaction.
  3. hypotension.
  4. organ rejection.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

fffftttt

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

Correct Answer: 3

Answer to Question 2

Correct Answer: 4




melina_rosy

  • Member
  • Posts: 531
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


ryhom

  • Member
  • Posts: 366
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

For a complete list of videos, visit our video library